Navigation Links
President Obama Must Investigate Reports of Detainee Abuse at Bagram Air Base
Date:5/11/2010

Physicians for Human Rights (PHR) today called on President Obama to investigate BBC News reports that detainees being held by US forces at an undisclosed second detention facility at Bagram Air Base in Afghanistan are allegedly being subjected to prolonged isolation, temperature manipulation, and sleep deprivation.

Cambridge, MA (Vocus) -- Physicians for Human Rights (PHR) today called on President Obama to investigate BBC News reports that detainees being held by US forces at an undisclosed second detention facility at Bagram Air Base in Afghanistan are allegedly being subjected to prolonged isolation, temperature manipulation, and sleep deprivation.

Those techniques—whether applied alone or in combination—can qualify as torture under US and international law, as demonstrated in the 2007 analysis by PHR and Human Rights First entitled Leave No Marks: Enhanced Interrogation Techniques and the Risk of Criminality and numerous US State Department human rights reports.

“These techniques, regardless of which administration employs them, constitute torture,” stated Frank Donaghue, CEO of Physicians for Human Rights. “President Obama has said that he has ended the previous administration’s use of torture. Until these reports are fully investigated and these tactics are explicitly prohibited, the president’s statements ring hollow.”

It is not yet clear under what authority, if any, the abusive techniques allegedly used at Bagram were approved, but it is possible that officials were relying on Appendix M of the 2006 Army Field Manual on Human Intelligence Collector Operations (AFM). That appendix authorizes the use of two of the tactics—sleep deprivation and isolation—allegedly being applied to detainees. The use of temperature manipulation is prohibited by the AFM. Since the release of the current AFM in September 2006, PHR has led the effort to rescind Appendix M.

“As long as Appendix M remains in effect, there is an asterisk next to the Obama administration’s claim that it does not authorize torture,” stated John Bradshaw, Washington Director of Physicians for Human Rights. “Appendix M’s approval of sleep manipulation and isolation is a green light for the abuse of the health and human rights of detainees in US custody. The abuses allowed under Appendix M—and any others still practiced—must come to an end.”

Physicians for Human Rights (PHR) mobilizes the health professions to advance the health and dignity of all people by protecting human rights. As a founding member of the International Campaign to Ban Landmines, PHR shared the 1997 Nobel Peace Prize.

Media Contacts:

Benjamin Greenberg
bgreenberg(at)phrusa(dot)org
+1-617-510-3417

Stephen Greene
sgreene(at)phrusa(dot)org
+1-617-909-9160

###

Read the full story at http://www.prweb.com/releases/2010/05/prweb3991214.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Statement From IHA President Maryjane A. Wurth on Illinois Supreme Court Medical Liability Ruling
2. Dr. Randy Miller Is Named President-Elect of the Florida Society of Plastic Surgeons
3. Allied World Appoints Theana Iordanou Vice President and New York Regional Branch Manager
4. Abington Health Announces New President and CEO
5. GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech
6. Presidents Budget for Global Health Far Short of Whats Needed - Congress Must Fix
7. TFAH Praises Presidents Budget for Consistent Commitment to Public Health and Prevention
8. Ophthalmic Women Leaders (OWL) Names Pamela Gleeson, CFO Of Santen Inc., as 2010 President
9. Susan P. Byrnes Health Education Center Names C.T. ODonnell President and CEO
10. President Obama Highlights Bipartisan Policy Center Health Care Reform Plan in Remarks to House Republicans
11. Statement From American Heart Association CEO Nancy Brown on President Obamas State of the Union Address
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
President Obama Must Investigate Reports of Detainee Abuse at Bagram Air Base 
(Date:5/23/2017)... ... May 23, 2017 , ... The Gallery ... Kevin Sadati, is pleased to announce a new treatment option called Vivace Microneedling. ... their face, neck, and body through a virtually pain-free, non-surgical treatment. Vivace Microneedling ...
(Date:5/23/2017)... ... May 23, 2017 , ... New patients from Charleston, SC, are ... dentist practicing in Mt. Pleasant, SC, with or without a referral. A full mouth ... with missing teeth in Charleston, SC. Those who suffer from gum disease, ...
(Date:5/23/2017)... WI (PRWEB) , ... May 23, 2017 , ... Patients ... to call Dr. Angela Cotey’s practice to schedule an appointment, with or without a ... and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative to a ...
(Date:5/22/2017)... PA (PRWEB) , ... May 22, 2017 , ... An ... to write with a pen. "My wife’s hand was damaged in a firework accident, ... something that helps people with manual problems." , He then designed and created a ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... larger group investing in InsightRX, an early stage company in San Francisco that ... pharmacological characteristics. Greatpoint Ventures Innovation Fund acted as the lead investor ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... -- Hologic, Inc. (Nasdaq: HOLX ) announced ... quarter ended April 1, 2017 .   GAAP diluted ... to the prior year period as the sale of ... while non-GAAP diluted EPS of $0.50 increased 6.4%.  Revenue ... currency terms.  Excluding the effects of blood screening and ...
Breaking Medicine Technology: